• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Reinsurance, Stop-Loss Programs in Managing High-Cost Meds, Per Rick Lassow of Summit Re | AMCP 2023

Video

At the annual AMCP meeting, Summit Re's Vice President of Actuarial & Underwriting, Rick Lassow, FSA, MAAA, led a discussion on managing high-cost medications through reinsurance and stop-loss programs. In this interview with Managed Healthcare Executive Lassow addresses high-cost cell and gene therapies ran through reinsurance and how Medicaid can benefit the most from reinsurance programs.

In this interview with Managed Healthcare Executive, Lassow addressed the situations of high-cost cell and gene therapies ran through reinsurance and how Medicaid can benefit the most from reinsurance programs.

As for gene and cell therapies, they're not much different from other high-investment drugs. He added these types of therapies could be more predictable when it comes to the patient condition because a gene therapy has a defined price take $2.5 to $3 million. Recovery time can be different, too. A burn victim, for example, can be treated differently or have different outcomes because these patients can be in the hospital for a week or more depending on the severity.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.